Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance-Reference-Cited by-同舟云学术

Characterization of Raloxifene Glucuronidation in Vitro: Contribution of Intestinal Metabolism to Presystemic Clearance

Published:2002-06-01 Issue:6 Volume:30 Page:694-700
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Kemp Daniel C.,Fan Peter W.,Stevens Jeffrey C.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference23 articles.

1. Cloning and Expression of Human UDP-Glucuronosyltransferase (UGT) 1A8

2. Glucuronidation of estrogens and retinoic acid and expression of UDP- glucuronosyltransferase 2B7 in human intestinal mucosa.;Czernik;Drug Metab Dispos,2000

3. Evaluation of the major metabolites of raloxifene as modulators of tissue selectivity

4. Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank

5. Glucuronidation of amines and hydroxylated xenobiotics and endobiotics catalyzed by expressed human UGT1.4 protein.;Green;Drug Metab Dispos,1996

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy;Nano Today;2024-08

2. Novel Treatment Strategies for Hormone Receptor (HR)-Positive, HER2-Negative Metastatic Breast Cancer;Journal of Clinical Medicine;2024-06-20

3. Interplay Between Metabolic Enzymes and Transporters;Oral Bioavailability and Drug Delivery;2023-10-10

4. Liver Drug Metabolism;Oral Bioavailability and Drug Delivery;2023-10-10

5. Drug Metabolism in Gastrointestinal Tract;Oral Bioavailability and Drug Delivery;2023-10-10